A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses

Lisa B. Dixon, Julie A. Kreyenbuhl, Faith B. Dickerson, Thomas W Donner, Clayton H. Brown, Karen Wolheiter, Leticia Postrado, Richard W. Goldberg, Lijuan Fang, Christopher Marano, Erick Messias

Research output: Contribution to journalArticle

Abstract

Objective: Type 2 diabetes is an important comorbid medical condition associated with schizophrenia. The objective of this study was to compare glycosylated hemoglobin (HbA 1c) levels of patients who had type 2 diabetes and schizophrenia with those of patients who had type 2 diabetes and major mood disorders and those who had type 2 diabetes but who did not have severe mental illness. Methods: A sample of 300 patients with type 2 diabetes was recruited from community mental health centers in the greater Baltimore region and nearby primary care clinics. Of these, 100 had schizophrenia, 101 had a major mood disorder, and 99 had no identified severe mental illness. HbA 1c, the main outcome measure, was compared between the group with schizophrenia and the other two groups. Results: All three groups had HbA 1c values above recommended levels. HbA 1c, levels were significantly lower among patients with schizophrenia than among patients who did not have severe mental illness but were not significantly different from those of patients who had major mood disorders. Patients for whom olanzapine was prescribed had higher HbA 1c, levels than those for whom other antipsychotic agents were prescribed. Conclusions: All three groups of patients require improved diabetes treatment to achieve acceptable HbA 1c, levels. There may be previously unrecognized benefits for diabetes management among persons with severe mental illnesses who are receiving regular mental heath care, but these individuals may also have risk factors that can influence diabetes outcomes and HbA 1c levels.

Original languageEnglish (US)
Pages (from-to)892-900
Number of pages9
JournalPsychiatric Services
Volume55
Issue number8
DOIs
StatePublished - Aug 2004

Fingerprint

mental illness
Type 2 Diabetes Mellitus
chronic illness
schizophrenia
human being
Schizophrenia
Mood Disorders
mood
olanzapine
Group
Community Mental Health Centers
Baltimore
Glycosylated Hemoglobin A
Antipsychotic Agents
Primary Health Care
mental health
Outcome Assessment (Health Care)
management
community
Values

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)

Cite this

Dixon, L. B., Kreyenbuhl, J. A., Dickerson, F. B., Donner, T. W., Brown, C. H., Wolheiter, K., ... Messias, E. (2004). A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses. Psychiatric Services, 55(8), 892-900. https://doi.org/10.1176/appi.ps.55.8.892

A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses. / Dixon, Lisa B.; Kreyenbuhl, Julie A.; Dickerson, Faith B.; Donner, Thomas W; Brown, Clayton H.; Wolheiter, Karen; Postrado, Leticia; Goldberg, Richard W.; Fang, Lijuan; Marano, Christopher; Messias, Erick.

In: Psychiatric Services, Vol. 55, No. 8, 08.2004, p. 892-900.

Research output: Contribution to journalArticle

Dixon, LB, Kreyenbuhl, JA, Dickerson, FB, Donner, TW, Brown, CH, Wolheiter, K, Postrado, L, Goldberg, RW, Fang, L, Marano, C & Messias, E 2004, 'A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses', Psychiatric Services, vol. 55, no. 8, pp. 892-900. https://doi.org/10.1176/appi.ps.55.8.892
Dixon, Lisa B. ; Kreyenbuhl, Julie A. ; Dickerson, Faith B. ; Donner, Thomas W ; Brown, Clayton H. ; Wolheiter, Karen ; Postrado, Leticia ; Goldberg, Richard W. ; Fang, Lijuan ; Marano, Christopher ; Messias, Erick. / A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses. In: Psychiatric Services. 2004 ; Vol. 55, No. 8. pp. 892-900.
@article{095d5033f21a4c3f9ce83e88e031ac0d,
title = "A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses",
abstract = "Objective: Type 2 diabetes is an important comorbid medical condition associated with schizophrenia. The objective of this study was to compare glycosylated hemoglobin (HbA 1c) levels of patients who had type 2 diabetes and schizophrenia with those of patients who had type 2 diabetes and major mood disorders and those who had type 2 diabetes but who did not have severe mental illness. Methods: A sample of 300 patients with type 2 diabetes was recruited from community mental health centers in the greater Baltimore region and nearby primary care clinics. Of these, 100 had schizophrenia, 101 had a major mood disorder, and 99 had no identified severe mental illness. HbA 1c, the main outcome measure, was compared between the group with schizophrenia and the other two groups. Results: All three groups had HbA 1c values above recommended levels. HbA 1c, levels were significantly lower among patients with schizophrenia than among patients who did not have severe mental illness but were not significantly different from those of patients who had major mood disorders. Patients for whom olanzapine was prescribed had higher HbA 1c, levels than those for whom other antipsychotic agents were prescribed. Conclusions: All three groups of patients require improved diabetes treatment to achieve acceptable HbA 1c, levels. There may be previously unrecognized benefits for diabetes management among persons with severe mental illnesses who are receiving regular mental heath care, but these individuals may also have risk factors that can influence diabetes outcomes and HbA 1c levels.",
author = "Dixon, {Lisa B.} and Kreyenbuhl, {Julie A.} and Dickerson, {Faith B.} and Donner, {Thomas W} and Brown, {Clayton H.} and Karen Wolheiter and Leticia Postrado and Goldberg, {Richard W.} and Lijuan Fang and Christopher Marano and Erick Messias",
year = "2004",
month = "8",
doi = "10.1176/appi.ps.55.8.892",
language = "English (US)",
volume = "55",
pages = "892--900",
journal = "Psychiatric Services",
issn = "1075-2730",
publisher = "American Psychiatric Association",
number = "8",

}

TY - JOUR

T1 - A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses

AU - Dixon, Lisa B.

AU - Kreyenbuhl, Julie A.

AU - Dickerson, Faith B.

AU - Donner, Thomas W

AU - Brown, Clayton H.

AU - Wolheiter, Karen

AU - Postrado, Leticia

AU - Goldberg, Richard W.

AU - Fang, Lijuan

AU - Marano, Christopher

AU - Messias, Erick

PY - 2004/8

Y1 - 2004/8

N2 - Objective: Type 2 diabetes is an important comorbid medical condition associated with schizophrenia. The objective of this study was to compare glycosylated hemoglobin (HbA 1c) levels of patients who had type 2 diabetes and schizophrenia with those of patients who had type 2 diabetes and major mood disorders and those who had type 2 diabetes but who did not have severe mental illness. Methods: A sample of 300 patients with type 2 diabetes was recruited from community mental health centers in the greater Baltimore region and nearby primary care clinics. Of these, 100 had schizophrenia, 101 had a major mood disorder, and 99 had no identified severe mental illness. HbA 1c, the main outcome measure, was compared between the group with schizophrenia and the other two groups. Results: All three groups had HbA 1c values above recommended levels. HbA 1c, levels were significantly lower among patients with schizophrenia than among patients who did not have severe mental illness but were not significantly different from those of patients who had major mood disorders. Patients for whom olanzapine was prescribed had higher HbA 1c, levels than those for whom other antipsychotic agents were prescribed. Conclusions: All three groups of patients require improved diabetes treatment to achieve acceptable HbA 1c, levels. There may be previously unrecognized benefits for diabetes management among persons with severe mental illnesses who are receiving regular mental heath care, but these individuals may also have risk factors that can influence diabetes outcomes and HbA 1c levels.

AB - Objective: Type 2 diabetes is an important comorbid medical condition associated with schizophrenia. The objective of this study was to compare glycosylated hemoglobin (HbA 1c) levels of patients who had type 2 diabetes and schizophrenia with those of patients who had type 2 diabetes and major mood disorders and those who had type 2 diabetes but who did not have severe mental illness. Methods: A sample of 300 patients with type 2 diabetes was recruited from community mental health centers in the greater Baltimore region and nearby primary care clinics. Of these, 100 had schizophrenia, 101 had a major mood disorder, and 99 had no identified severe mental illness. HbA 1c, the main outcome measure, was compared between the group with schizophrenia and the other two groups. Results: All three groups had HbA 1c values above recommended levels. HbA 1c, levels were significantly lower among patients with schizophrenia than among patients who did not have severe mental illness but were not significantly different from those of patients who had major mood disorders. Patients for whom olanzapine was prescribed had higher HbA 1c, levels than those for whom other antipsychotic agents were prescribed. Conclusions: All three groups of patients require improved diabetes treatment to achieve acceptable HbA 1c, levels. There may be previously unrecognized benefits for diabetes management among persons with severe mental illnesses who are receiving regular mental heath care, but these individuals may also have risk factors that can influence diabetes outcomes and HbA 1c levels.

UR - http://www.scopus.com/inward/record.url?scp=3543143156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543143156&partnerID=8YFLogxK

U2 - 10.1176/appi.ps.55.8.892

DO - 10.1176/appi.ps.55.8.892

M3 - Article

C2 - 15292539

AN - SCOPUS:3543143156

VL - 55

SP - 892

EP - 900

JO - Psychiatric Services

JF - Psychiatric Services

SN - 1075-2730

IS - 8

ER -